← Evidence map

ReviewCurrent neuropharmacology2022

Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

54 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34279201